(19)
(11) EP 2 015 776 A1

(12)

(43) Date of publication:
21.01.2009 Bulletin 2009/04

(21) Application number: 07761070.7

(22) Date of filing: 20.04.2007
(51) International Patent Classification (IPC): 
A61K 39/395(2006.01)
C07K 16/26(2006.01)
C07K 14/605(2006.01)
(86) International application number:
PCT/US2007/067152
(87) International publication number:
WO 2007/124463 (01.11.2007 Gazette 2007/44)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK RS

(30) Priority: 20.04.2006 US 793690 P

(71) Applicant: Amgen Inc.
Thousand Oaks, CA 91320-1799 (US)

(72) Inventors:
  • SHEN, Wenyan
    Palo Alto, CA 94303 (US)
  • GRAHAM, Kevin
    Thousand Oaks, CA 91362 (US)
  • WINTERS, Katherine, Ann
    Thousand Oaks, CA 91360 (US)
  • VENIANT-ELLISON, Murielle
    Thousand Oaks, CA 91360 (US)
  • BOONE, Thomas, Charles
    Newbury Park, CA 91320 (US)

(74) Representative: Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät 
Leopoldstrasse 4
80802 München
80802 München (DE)

   


(54) GLP-1 COMPOUND/GLUCAGON ANTIBODY COMPOSITIONS